For example, Roche's rabbit mAb anti-HER-2/neu (4B5) is utilized in immunohistochemical staining to confirm HER2-low status in breast cancer prior to treatment with trastuzumab deruxtecan [78]. This evidence concerns the gene ERBB2 and breast cancer.